NOVARTIS GENE THERAPIES EU LIMITED (FC035877)

NOVARTIS GENE THERAPIES EU LIMITED (Company No. FC035877) was an overseas company incorporated on 1 January 2019 and registered in the United Kingdom. It ceased trading and closed on 11 January 2023 following the dissolution of its UK establishment.

The company’s registered office was located at Block B, The Crescent Building, Northwood, Santry, Dublin 9, Ireland. Its last accounts were made up to 31 December 2017.

At the time of closure, the officers were Kirsten Broeckers (German, resident in Switzerland), who served as both director and secretary, and Martin Guyot (Swiss, resident in Switzerland), who was appointed as a director in July 2019.

The company had no charges, no insolvency history, and no persons with significant control registered in the UK. The final filing on 11 January 2023 recorded the dissolution and closure of the UK establishment.